Research location

Gonesse

France

Published trials33

Site observations33

Linked trials published33

Page1 / 1

Research activity in Gonesse

France

CureCurrent currently publishes aggregate city-level research activity for this location: 33 trials and 33 site observations.

The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.

Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.

Trials with sites in Gonesse

33 linked trials · page 1 of 1

A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple SclerosisNCT07225504 · 2025-11-11 · 1 site observation

RItuximab Versus Ocrelizumab in Relapsing-remitting Multiple Sclerosis.NCT05758831 · 2023-06-01 · 1 site observation

French Registry for Monitoring Pregnancies for Multiple SclerosisNCT03900221 · 2019-08-12 · 1 site observation

Disease Modifying Therapies Withdrawal in Inactive Relapsing-remitting Multiple Sclerosis Patients Aged 55 and Over (TWINS : Therapies Withdrawal IN Relapsing Multiple Sclerosis)NCT06663189 · 2025-01-01 · 1 site observation

NOT_YET_RECRUITING

A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis.NCT06372145 · 2024-04-16 · 1 site observation

ACTIVE_NOT_RECRUITING

Evaluation of Security and Efficacy of Medtrum Hybrid Closed Loop SystemNCT06363916 · 2024-04-15 · 1 site observation

Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple SclerosisNCT06141486 · 2023-12-27 · 1 site observation

ACTIVE_NOT_RECRUITING

Assessment of the Quality of Life of Multiple Sclerosis Patients Treated With Ofatumumab in Real-life in FranceNCT06157086 · 2023-12-21 · 1 site observation

ACTIVE_NOT_RECRUITING

Impact of Annual Versus Biannual Infusions of Ocrelizumab in Patients With Active MS,After 2 Years of Initial Treatment, on Freedom From Radiological Disease Activity at Two Years: a Multicenter Randomized Controlled Non-inferiority TrialNCT05999604 · 2023-11-09 · 1 site observation

ACTIVE_NOT_RECRUITING

Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) (REMODEL-2)NCT05156281 · 2021-12-13 · 1 site observation

ACTIVE_NOT_RECRUITING

Open Label Randomized Multicenter to Assess Efficacy & Tolerability of Ofatumumab 20mg vs. First Line DMT in RMSNCT04788615 · 2021-07-23 · 1 site observation

Validation of the French Adaptation of the MSWDQ-23 QuestionnaireNCT04860791 · 2021-05-10 · 1 site observation

Cognition and HRQoL in Adults With Highly-active RMS in Year 3 and 4 After Initial Mavenclad® Dose (CLARIFY MS Extension)NCT04776213 · 2021-02-23 · 1 site observation

Nonrelapsing Secondary Progressive Multiple Sclerosis (NRSPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (HERCULES)NCT04411641 · 2020-09-24 · 1 site observation

Primary Progressive Multiple Sclerosis (PPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (PERSEUS)NCT04458051 · 2020-08-13 · 1 site observation

Safety and Performance Assessment of Drug-Eluting Stent CRE8 in Diabetic PatientsNCT03842813 · 2019-04-09 · 1 site observation

A Study to Provide Complementary Efficacy, Safety and Patient Reported Outcomes Data in Participants With Active Relapsing Forms of Multiple Sclerosis (MS) in a Pragmatic SettingNCT03589105 · 2018-08-06 · 1 site observation

This is an Extension Study of the Roche P-trials to Investigate Safety and Effectiveness of Ocrelizumab in Participants With Multiple Sclerosis (MS)NCT03599245 · 2018-07-12 · 1 site observation

Study to Evaluate the Effectiveness and Safety of Ocrelizumab in Participants With Early Stage Relapsing Remitting Multiple Sclerosis (RRMS)NCT03085810 · 2017-03-24 · 1 site observation

Plegridy Observational ProgramNCT02230969 · 2014-11-12 · 1 site observation

Heart Failure Educational and Follow up PlatformNCT02110433 · 2013-12-01 · 1 site observation

Dimethyl Fumarate (DMF) Observational StudyNCT02047097 · 2013-11-19 · 1 site observation

An Observational Study of Avastin (Bevacizumab) in Elderly Patients With Non-Squamous Non-Small Cell Lung Cancer in Clinical PracticeNCT01893268 · 2013-07-25 · 1 site observation

PEPITA Study: An Observational Study of Tarceva (Erlotinib) in Second Line in Patients With Locally Advanced or Metastatic Squamous Non-Small Cell Lung CancerNCT01659970 · 2012-06-01 · 1 site observation

An Observational Study to Collect Information on Safety and to Document the Drug Utilization of Fampyra (BIIB041) When Used In Routine Medical PracticeNCT01480063 · 2012-04-16 · 1 site observation

HIV-1 Infected Adult Subjects With HIV-associated Neurocognitive Disorders Despite Effective Antiretroviral TherapyNCT04266002 · 2011-11-01 · 1 site observation

A Study to Assess Dolutegravir in HIV-infected Subjects With Treatment Failure on an Integrase Inhibitor Containing Regimen.NCT01328041 · 2011-05-01 · 1 site observation

European Non-interventional Study in Chronic Obstructive Pulmonary Disease (COPD) PatientsNCT00722267 · 2008-07-01 · 1 site observation

National Survey on Hypertension at HospitalNCT00695266 · 2007-12-01 · 1 site observation

Cardiovascular Risk Assessment in Patients Treated With CaduetNCT00297973 · 2006-02-01 · 1 site observation

Crestor Versus Placebo in Subjects With Heart FailureNCT00206310 · 2003-09-01 · 1 site observation

Post-marketing Observational Study in Subjects With Rheumatoid ArthritisNCT00234884 · 2003-09-01 · 1 site observation

Study on the Effectiveness of EGb 761® vs Placebo Used for Cognitive Impairment in Patients With Multiple SclerosisNCT00276341 · 2003-08-26 · 1 site observation

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.